العلاج (المساعد أو المتتالي) الكيمائي والهرموني في مرحلة مبكرة من الأصابة بمرض سرطان الثدي لدي كبار السن
Shaymaa Mamdouh Anwar;
Abstract
SUMMARY
In the U.S., cancer is a disease of aging. The average 65-year-old patient has an anticipated life expectancy of 20 years, and clinicians should take this into account when making breast cancer management decisions.
However, older breast cancer p
In the U.S., cancer is a disease of aging. The average 65-year-old patient has an anticipated life expectancy of 20 years, and clinicians should take this into account when making breast cancer management decisions.
However, older breast cancer p
Other data
| Title | العلاج (المساعد أو المتتالي) الكيمائي والهرموني في مرحلة مبكرة من الأصابة بمرض سرطان الثدي لدي كبار السن | Other Titles | العلاج (المساعد أو المتتالي) الكيمائي والهرموني في مرحلة مبكرة من الأصابة بمرض سرطان الثدي لدي كبار السن | Authors | Shaymaa Mamdouh Anwar | Keywords | العلاج (المساعد أو المتتالي) الكيمائي والهرموني في مرحلة مبكرة من الأصابة بمرض سرطان الثدي لدي كبار السن | Issue Date | 2013 | Description | SUMMARY In the U.S., cancer is a disease of aging. The average 65-year-old patient has an anticipated life expectancy of 20 years, and clinicians should take this into account when making breast cancer management decisions. However, older breast cancer p |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 117425final master_Final.pdf | 433.3 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.